High levels of serum CA15‐3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non‐pathological complete response after neoadjuvant chemotherapy
Year: 2018
Type: article
Study design: Observational Study
Source: Journal of Surgical Oncology
DOI: 10.1002/jso.25125
Institution: Hyogo Medical University
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Hyogo College of Medicine
OpenAlex ID: W2811042001
